Skip to content
About
Science
Pipeline
News
Careers
Partnering
News
Press Releases
03/03/2026
Syntis Bio Announces First Patient Dosed in Phase 1/1b Clinical Trial of SYNT-101 in Obesity and Key Leadership Additions
Read More
Press Releases
07/01/2025
Syntis Bio Closes $38 Million Financing to Accelerate Oral Therapies for Obesity and Rare Diseases
Read More
In The News
04/10/2025
WIRED Magazine: An Experimental Obesity Pill Mimics Gastric Bypass Surgery
Read More
Press Releases
04/10/2025
Syntis Bio Releases New Data Supporting Potential of SYNT-101 as a Once-Daily Oral Treatment for Obesity at European Congress on Obesity and Weight Management
Read More
Press Releases
06/11/2024
Syntis Bio Launches to Revolutionize Oral Therapy for Obesity, Diabetes and Rare Diseases by Unlocking the Full Therapeutic Potential of the Small Intestine
Read More
In The News
04/05/2021
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Read More
Top
